This compound is a benzimidazole derivative featuring a tetrazole-bearing biphenyl substituent and an ethyl ester group. It is primarily utilized as an intermediate in the synthesis of pharmaceutical agents, particularly those targeting the angiotensin II receptor.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 139481-58-6
Methyl candesartan
pharmaceutical intermediate for prodrug synthesis
Kandesartan
active pharmaceutical ingredient
2-Ethoxy-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid
Pharmaceutical intermediate for candesartan
16alpha-Hydroxyprednisolone
pharmaceutical raw material
2-(7-METHOXY-1-NAPHTHYL)ETHYLAMINE HYDROCHLORIDE
pharmaceutical intermediate
Fmoc-beta-t-butyl-L-alanine
peptide synthesis building block
ethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
BCPWNYREAURMOP-UHFFFAOYSA-N
CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)OCC